CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 37,695 shares (option exercise)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 81,933 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF R&D gave up 64,373 shares (to pay taxes)
- 4 Open-market buy INTERIM CFO bought 50,000 shares at $0.72 ($36,000)
- 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
- 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 1,835 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 29 · 574 filings